Ticker Details
Krystal Biotech, Inc. Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$10.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.28 | 2.68%
Avg Daily Range (30 D):	$9.30 | 2.67%
Avg Daily Range (90 D):	$6.78 | 2.08%

Institutional Daily Volume
Avg Daily Volume:	.17M
Avg Daily Volume (30 D):	.34M
Avg Daily Volume (90 D):	.28M

Trade Size
Avg Trade Size (Sh.):	40
Avg Trade Size (Sh.) (30 D):	27
Avg Trade Size (Sh.) (90 D):	25

Institutional Trades
Total Institutional Trades:	2,434
Avg Institutional Trade:	$5.35M
Avg Institutional Trade (30 D):	$35.25M
Avg Institutional Trade (90 D):	$22.78M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.63M
Avg Closing Trade (30 D):	$40.23M
Avg Closing Trade (90 D):	$25.34M
Avg Closing Volume:	43.46K

News

Jul 23, 2026 @ 9:00 PM Krystal Biotech to Report Second Quarter 2026 Fina... Source: Na

Jul 21, 2026 @ 10:00 PM Why Tutor Perini Stock Trounced the Market on Tues... Source: Eric Volkman

Jul 7, 2026 @ 11:15 PM 3 Soaring Stocks That May Have More Upside Ahead Source: Prosper Junior Bakiny

Jun 18, 2026 @ 5:30 AM These 3 Stocks Have Crushed the Market This Year. ... Source: Prosper Junior Bakiny

Apr 30, 2026 @ 12:00 PM Krystal Biotech to Present at Upcoming Scientific ... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$8.27	$1.85	$1.91
Diluted EPS	$7.98	$1.79	$1.83
Revenue	$440.48M	$119.22M	$116.36M
Gross Profit
Net Income / Loss	$241.47M	$54.77M	$55.93M
Operating Income / Loss	$197.75M	$58.42M	$53.69M
Cost of Revenue
Net Cash Flow	$73.91M	$-73.57M	$5.01M
PE Ratio